Merck KGaA (ETR:MRK)
124.60
+2.70 (2.21%)
May 2, 2025, 5:35 PM CET
Merck KGaA Employees
Merck KGaA had 59,020 employees as of December 31, 2024. The number of employees decreased by 3,888 or -6.18% compared to the previous year.
Employees
59,020
Change (1Y)
-3,888
Growth (1Y)
-6.18%
Revenue / Employee
€358,455
Profits / Employee
€47,052
Market Cap
54.17B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 59,020 | -3,888 | -6.18% |
Dec 31, 2023 | 62,908 | -1,324 | -2.06% |
Dec 31, 2022 | 64,232 | 3,898 | 6.46% |
Dec 31, 2021 | 60,334 | 2,207 | 3.80% |
Dec 31, 2020 | 58,127 | 1,056 | 1.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 176,486 |
Bayer Aktiengesellschaft | 90,587 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
SCHOTT Pharma AG & Co. KGaA | 4,690 |
Merck KGaA News
- 3 days ago - SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO - Seeking Alpha
- 4 days ago - SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating SpringWorks Therapeutics, Inc. Buyout - Wallstreet:Online
- 5 days ago - SWTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SpringWorks Therapeutics, Inc. Is Fair to Shareholders - Wallstreet:Online
- 5 days ago - Germany's Merck Agrees to Buy US Biotech SpringWorks Therapeutics for Almost $4B - Investopedia
- 5 days ago - Wall Street Breakfast Podcast: Huawei Preps AI Chip To Challenge Nvidia: Report - Seeking Alpha
- 5 days ago - Santé : Merck KGaA acquiert l'américain SpringWorks Therapeutics pour 3,4 milliards de dollars - Le Figaro
- 5 days ago - Merck KGaA (MKGAF) to Acquire SpringWorks Therapeutics for $3.9 Billion - GuruFocus
- 5 days ago - Merck KGaA to Acquire SpringWorks Therapeutics for $3.9 Billion | SWTX stock news - GuruFocus